ABBV vs IQV
AbbVie vs IQVIA — AI-powered side-by-side comparison
| Metric | ABBV | IQV |
|---|
| AI Score |
69
|
70
|
| Price |
$249.34
|
$236.69
|
| P/E Ratio |
70.28×
|
29.11×
|
| ROE |
-129.2%
|
20.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
71.5%
|
26.2%
|
| Debt / Equity |
-11.93×
|
2.63×
|
| Dividend Yield |
2.7%
|
0.0%
|
| RSI (14) |
48.9
|
64.6
|
| Beta |
0.28
|
1.175
|
| Expected Upside |
—
|
+4.2%
|
AI Committee View
Current Innellis committee reasoning for ABBV versus IQV.
IQV leads by 1 points.
IQV scores 70/100 (Buy) versus ABBV at 69/100 (Buy).
ABBV Committee View
75% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- News sentiment is positive (+0.20 across 84 articles, 14d) — News
Bear Case
- MACD histogram negative -- bearish momentum — Technical
IQV Committee View
60% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
- Weekly RSI at 81 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 30.0% signals elevated volatility — Risk